Nilotinib: selective inhibitor as second-line therapy
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd
2015-10-01
|
| Series: | Clinical Management Issues |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1096 |
| _version_ | 1819276987355627520 |
|---|---|
| author | Massimo Breccia |
| author_facet | Massimo Breccia |
| author_sort | Massimo Breccia |
| collection | DOAJ |
| first_indexed | 2024-12-23T23:48:57Z |
| format | Article |
| id | doaj.art-fceec72aaa9e4bbaac8e3a1a162b3d01 |
| institution | Directory Open Access Journal |
| issn | 1973-4832 2283-3137 |
| language | English |
| last_indexed | 2024-12-23T23:48:57Z |
| publishDate | 2015-10-01 |
| publisher | SEEd |
| record_format | Article |
| series | Clinical Management Issues |
| spelling | doaj.art-fceec72aaa9e4bbaac8e3a1a162b3d012022-12-21T17:25:27ZengSEEdClinical Management Issues1973-48322283-31372015-10-0146S3510.7175/cmi.v4i6S.10961027Nilotinib: selective inhibitor as second-line therapyMassimo Breccia0Dipartimento di Ematologia, Azienda Policlinico Umberto I°, Università Sapienza, Romahttps://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1096 |
| spellingShingle | Massimo Breccia Nilotinib: selective inhibitor as second-line therapy Clinical Management Issues |
| title | Nilotinib: selective inhibitor as second-line therapy |
| title_full | Nilotinib: selective inhibitor as second-line therapy |
| title_fullStr | Nilotinib: selective inhibitor as second-line therapy |
| title_full_unstemmed | Nilotinib: selective inhibitor as second-line therapy |
| title_short | Nilotinib: selective inhibitor as second-line therapy |
| title_sort | nilotinib selective inhibitor as second line therapy |
| url | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1096 |
| work_keys_str_mv | AT massimobreccia nilotinibselectiveinhibitorassecondlinetherapy |